February 24, 2023

MicroGenDX Next-Generation Sequencing PJI Study Named as JBJS Notable Article of 2022

The landmark 14-Site study on the role of Next-Generation Sequencing in Periprosthetic Joint Infections has been acknowledged by the journal as being one of the ten that “will have the greatest impact on patient care.”
June 14, 2022

MicroGenDX Provides Rapid Screening for Candida Auris to Help Avoid Outbreaks in Healthcare Settings

Candida auris causes serious infections, and cases are rising across the U.S…..MicroGenDX testing also facilitates the rapid intervention and precautions needed to prevent outbreaks in healthcare settings by returning results within 24-48 hours.
April 21, 2022

MicroGenDX Acquires Captigen and its Flatswab Inventory

MicroGenDX continues to expand its growth and expertise in molecular diagnostics by acquiring sampling innovator Captigen along with Captigen’s extensive inventory of flatswabs. The Captigen flatswab is a cross-platform precision microbial sampling device designed for optimized culture yield, RT-PCR yield, and next-generation sequencing (NGS).